0      0


Individualised Neo-Antigen-Specific Therapies: Unique CMC Challenges and a Novel Regulatory Framework


Sep 23, 2021 2:00pm ‐ Sep 23, 2021 2:20pm


Credits: None available.

Description

Individualised Neo-Antigen-Specific Therapies: Unique CMC Challenges and a Novel Regulatory Framework|

Speaker(s):

  • Amy Hardwick, Technical Regulatory Program Associate Director, INeST, Genentech

Credits

Credits: None available.

You must be logged in and own this session in order to post comments.